Profile data is unavailable for this security.
About the company
Animalcare Group plc is a United Kingdom-based international veterinary sales and marketing company. The Company is focused on bringing products to market through its own development pipeline, partnerships and through acquisitions. The Company develops and commercializes prescription and over-the-counter pharmaceutical products that improve animal health and wellbeing. These are developed in-house, acquired from other companies or in-licensed from its partners. The Company manages an international supply chain, including specialist veterinary wholesalers and distributors. It partners with companies to commercialize products across Europe. The Company operates in three categories within the veterinary market: companion animals, equine and other, and production animals. Its product pipeline is Daxocox, which is a differentiated COX-2 inhibitor for the treatment of chronic pain in dogs. The Company operates in seven countries and exports to about 40 countries in Europe and worldwide.
- Revenue in GBP (TTM)74.35m
- Net income in GBP1.20m
- Incorporated1972
- Employees220.00
- LocationAnimalcare Group plcMoorside, Monks CrossYORK YO32 9LBUnited KingdomGBR
- Phone+44 19 0448 7687Fax+44 19 0448 7611
- Websitehttps://www.animalcaregroup.com/
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
Eco Animal Health Group Plc | 88.46m | -1.62m |
Scancell Holdings Plc | 0.00 | -11.32m |
Futura Medical PLC | 3.10m | -6.51m |
Animalcare Group Plc | 74.35m | 1.20m |
Allergy Therapeutics plc | 53.26m | -50.22m |
Avacta Group Plc | 16.03m | -42.08m |
Faron Pharmaceuticals Oy | 0.00 | -26.49m |
4Basebio PLC | 354.00k | -6.28m |
hVIVO PLC | 56.04m | 16.12m |
Alliance Pharma plc | 170.05m | -7.06m |
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
Liontrust Investment Partners LLPas of 31 Mar 2023 | 7.58m | 12.62% |
Harwood Capital LLPas of 07 Nov 2023 | 4.25m | 7.07% |
Canaccord Genuity Wealth Ltd.as of 31 Mar 2023 | 3.96m | 6.59% |
SEB Investment Management AB (Denmark)as of 30 Apr 2024 | 3.59m | 5.98% |
BGF Investment Management Ltd.as of 31 Mar 2023 | 3.56m | 5.92% |
BlackRock Investment Management (UK) Ltd.as of 24 Jan 2024 | 3.00m | 4.99% |
SEB Investment Management ABas of 31 Mar 2023 | 2.36m | 3.93% |
Octopus Investments Ltd.as of 20 Dec 2022 | 1.70m | 2.83% |
Unicorn Asset Management Ltd.as of 02 Nov 2023 | 1.68m | 2.80% |
Skandinaviska Enskilda Banken AB (Denmark)as of 30 Apr 2024 | 1.11m | 1.85% |